[Physio-pharmacology of coronary insufficiency. I].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000680:Amyl Nitrite / Q000627:therapeutic use; D000818:Animals; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use; D006329:Heart Conduction System / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009206:Myocardium / Q000378:metabolism; D009573:Nitrites / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D010101:Oxygen Consumption; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use; D011188:Potassium / Q000378:metabolism; D011217:Practolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014666:Vasomotor System / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D009573:Nitrites; D014665:Vasodilator Agents; D010417:Pentaerythritol Tetranitrate; D004176:Dipyridamole; D000680:Amyl Nitrite; D011433:Propranolol; D005996:Nitroglycerin; D011188:Potassium; D011217:Practolol
Fisio-farmacologia delle insufficienze coronariche. I